UPDATE 2-AstraZeneca taps Emergent as US partner for potential COVID-19 vaccine
June 11, 2020 at 12:42 PM EDT
AstraZeneca Plc on Thursday picked Emergent BioSolutions Inc to help produce the 300 million doses of the British drugmaker's potential COVID-19 vaccine pledged to the United States.
